Chris Markoch, Editor & Contributing Author at MarketBeat Articles by Chris Markoch - Page 24March 15, 2023 5:12 AM ET3 Sports Betting Stocks That Don’t Feel Like a GambleChris MarkochNYSE:MGMNASDAQ:DKNGNYSE:BYDRead 3 Sports Betting Stocks That Don’t Feel Like a GambleMarch 14, 2023 5:30 AM ETBonds are a Safe Haven Again, Still Time to Buy?Chris MarkochNASDAQ:SIVBNYSE:GSRead Bonds are a Safe Haven Again, Still Time to Buy?March 13, 2023 6:00 AM ETCrocs May be a Comfortable Fit for Growth-Oriented InvestorsChris MarkochNASDAQ:CROXRead Crocs May be a Comfortable Fit for Growth-Oriented InvestorsMarch 13, 2023 5:03 AM ETIs Bionano Genomics a Risk Worth Taking at This Price?Chris MarkochNASDAQ:BNGORead Is Bionano Genomics a Risk Worth Taking at This Price?March 13, 2023 4:45 AM ETPatience, Not Panic, Should be Your Playbook After SVB CollapseChris MarkochNASDAQ:SIVBRead Patience, Not Panic, Should be Your Playbook After SVB CollapseMarch 10, 2023 9:30 AM ETCan Investors Trust Consumers to Lift American Outdoor Brands?Chris MarkochNASDAQ:AOUTNASDAQ:SWBIRead Can Investors Trust Consumers to Lift American Outdoor Brands?March 10, 2023 5:15 AM ETSolo Brands May Remind Investors Why Cash is KingChris MarkochNYSE:DTCNASDAQ:AOUTRead Solo Brands May Remind Investors Why Cash is KingMarch 9, 2023 4:45 AM ETZymeworks Offers Hope for More than Just Long-Term InvestorsChris MarkochNYSE:ZYMENASDAQ:JAZZRead Zymeworks Offers Hope for More than Just Long-Term InvestorsMarch 9, 2023 4:00 AM ETAre Korn Ferry’s Results a Canary in the Employment Coal Mine?Chris MarkochNYSE:KFYRead Are Korn Ferry’s Results a Canary in the Employment Coal Mine?March 8, 2023 9:00 AM ETShould You Park Some Capital with Casey’s General Stores?Chris MarkochNASDAQ:CASYNYSE:JPMNYSE:RYRead Should You Park Some Capital with Casey’s General Stores?March 2, 2023 5:00 AM ETRivian Gives Investors a Taste of the Anxiety Its Consumers FeelChris MarkochNASDAQ:RIVNRead Rivian Gives Investors a Taste of the Anxiety Its Consumers FeelMarch 1, 2023 5:00 AM ETWhich Dollar Store, If Any, is Worth Your Investment Dollars?Chris MarkochNYSE:DGNASDAQ:DLTRNASDAQ:FIVERead Which Dollar Store, If Any, is Worth Your Investment Dollars?February 28, 2023 5:03 AM ETWhy Government Contracts are a Blessing and Curse for Rocket LabChris MarkochNASDAQ:RKLBRead Why Government Contracts are a Blessing and Curse for Rocket LabFebruary 27, 2023 9:38 AM ETCruise Line Stocks Still Have Some Choppy Waters to NavigateChris MarkochNYSE:RCLNYSE:NCLHNYSE:CCLRead Cruise Line Stocks Still Have Some Choppy Waters to NavigateFebruary 27, 2023 4:50 AM ETWill Lower Demand Take a Bite Out of Domino's Pizza Stock?Chris MarkochNYSE:DPZRead Will Lower Demand Take a Bite Out of Domino's Pizza Stock?February 21, 2023 5:12 AM ETWhy Albemarle Stock is a Long-Term Buy for an Inevitable Future?Chris MarkochNYSE:ALBNYSE:SQMRead Why Albemarle Stock is a Long-Term Buy for an Inevitable Future?February 20, 2023 6:00 AM ETCould Copper be the Shiny Object That Lifts Barrick Gold?Chris MarkochNYSE:GOLDRead Could Copper be the Shiny Object That Lifts Barrick Gold?February 17, 2023 8:00 AM ETDeere Stock Raises Outlook and is Ready to Power HigherChris MarkochNYSE:DERead Deere Stock Raises Outlook and is Ready to Power HigherFebruary 17, 2023 5:00 AM ETIs it Time to Fade the Rally in Generac Stock?Chris MarkochNYSE:GNRCRead Is it Time to Fade the Rally in Generac Stock?February 13, 2023 5:00 AM ETAbbVie Has a Mixed Outlook After Mixed EarningsChris MarkochNYSE:ABBVRead AbbVie Has a Mixed Outlook After Mixed EarningsFebruary 9, 2023 5:00 AM ETEnphase Energy May be Offering Investors a Second ChanceChris MarkochNASDAQ:ENPHRead Enphase Energy May be Offering Investors a Second ChanceFebruary 7, 2023 9:05 AM ETShould Investors Buy or Sell the Vaccinex Patent News?Chris MarkochNASDAQ:VCNXNYSE:MRKRead Should Investors Buy or Sell the Vaccinex Patent News?February 7, 2023 5:00 AM ETIs Merck Stock a Buy After Its Post-Earnings Sell-Off?Chris MarkochNYSE:MRKRead Is Merck Stock a Buy After Its Post-Earnings Sell-Off?February 3, 2023 9:40 AM ETZimmer Biomet Beats on Earnings, Growth May be Priced InChris MarkochNYSE:ZBHNYSE:RYRead Zimmer Biomet Beats on Earnings, Growth May be Priced In Page 24 of 44 « Most Recent‹ More Recent21222324252627 Earlier › Earliest » Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
